Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login
Journal of Cancer Research and Therapeutics, a publication of Association of Radiation Oncologists of India (AROI), is a peer-reviewed online journal with Quarterly print on demand compilation of issues published. The journalís full text is available online at http://www.cancerjournal.net. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository. The journal does not charge for submission, processing or publication of manuscripts and even for color reproduction of photographs.
CURRENT COVER
EDITORIAL BOARD

Editor in Chief
Dr. Nagraj Huilgol

Executive Editor
Rajiv Sarin, Mumbai, India

Associate Editor
Rakesh Jalali, Mumbai, India

View All Members

JCRT STATISTICS
  • 1,643 Total articles
  • 1,643 Full text articles
  • 106 Manuscripts submitted in '15
  • 56,011 Articles downloaded in 'December 2014

Special Issue

September 2013 Volume 9 | Issue 5 (Supplement)

Special Issue

November 2013 Volume 9 | Issue 7 (Supplement)

CURRENT ISSUE
October-December 2014| Vol 10| Issue 4

Editorial

Orphans of oncology

Science and medicine are replete with ideas which failed or never took off. The process of enquiry is not only complex but risky as well. The adage right man at the right time always succeeds, perhaps...


Review Article

The value of the systematic inflammation-based Glasgow Prognostic Score in patients with gastric cancer: A literature review

The presence of a systemic inflammatory response (SIR) is recognized to occur in the presence of malignancy. And the SIR-Glasgow Prognostic Score (GPS)/modified GPS (mGPS) composed of the C-reactive p...


Review Article

Regulatory mechanisms and clinical perspectives of miR-34a in cancer

MicroRNAs (miRNAs) are evolutionarily conserved, endogenous, noncoding RNA molecules of about 22-24 nucleotides in length that repress gene expression at the posttranscriptional level. MiR-34a plays a...


Review Article

Reactive oxygen species as mediator of tumor radiosensitivity

In normal functioning of the cell, there is a balance between generation and neutralization of reactive oxygen species (ROS) by endogenous cellular defense machinery. Low levels of ROS inside the cell...


View All Articles